Science Advances·7 August 2026
Liraglutide lowers a key water balancing hormone in healthy people and changes related proteins in rats.
A diabetes and weight loss drug called liraglutide lowers a hormone that helps the body hold onto water. This hormone is called vasopressin. In healthy people, the drug reduced blood levels of this hormone. In rats, the drug changed proteins inside the brain gland that makes this hormone. These changes were different in males and females. The drug also changed a water channel in the kidney that responds to this hormone.
Shown in healthy human volunteers and in rat brain and kidney tissue, not in patients with disease.
Small human trial plus rat experiments only, not a patient outcome study.
Integrity screen: passed (3 checks) Checked 11 August 2026. Michael P. Greenwood, Mohammed I. Alotaibi et al., A clinical and experimental investigation of liraglutide effects on the brain-kidney axis Read the source